Search Press releases
21 Jan 2022
Positive Top-Line Results for BIMZELX[®]▼(bimekizumab) in Second Phase 3 Psoriatic Arthritis Study
Read More
19 Jan 2022
UCB to acquire Zogenix
Read More
18 Jan 2022
Positive Top-Line Results for BIMZELX[®]▼(bimekizumab) in Phase 3 Non-Radiographic Axial Spondyloarthritis Study
Read More
8 Jan 2022
Disposals of own shares
Read More
3 Jan 2022
Disposals of own shares
Read More
21 Dec 2021